Hyaluronidase-Facilitated SCIG PK Compared in Pediatric and Adult PI Patients
Three phase 3 trials examined hyaluronidase-facilitated subcutaneous immunoglobulin 10% pharmacokinetics in pediatric and adult primary immunodeficiency patients.
Oct 19, 2026